Optimal Dose of Intravenous Cyclophosphamide during remission induction therapy in ANCA-associated vasculitis: a retrospective cohort study of J-CANVAS.
Hideaki SofueTakashi KidaAiko HiranoSatoshi OmuraMasatoshi KadoyaDaiki NakagomiYoshiyuki AbeNaoho TakizawaAtsushi NomuraYuji KukidaNaoya KondoYasuhiko YamanoTakuya YanagidaKoji EndoShintaro HirataKiyoshi MatsuiTohru TakeuchiKunihiro IchinoseMasaru KatoRyo YanaiYusuke MatsuoYasuhiro ShimojimaRyo NishiokaRyota OkazakiTomoaki TakataTakafumi ItoMayuko MoriyamaAyuko TakataniYoshia MiyawakiToshiko Ito-IharaNobuyuki YajimaTakashi KawaguchiKazuki FujiokaWataru FujiiTakahiro SenoMakoto WadaMasataka KohnoYutaka KawahitoPublished in: Modern rheumatology (2023)
Low-dose IVCY (7.5-12.5 mg/kg) may result in fewer infections and similar relapse rates compared with the conventional regimen (>12.5 mg/kg).